India · Delayed Price · Currency is INR Ipca Laboratories Statistics
Total Valuation
NSE:IPCALAB has a market cap or net worth of INR 483.31 billion. The enterprise value is 494.68 billion.
| Market Cap | 483.31B |
| Enterprise Value | 494.68B |
Important Dates
The last earnings date was Thursday, November 5, 2026.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | Aug 7, 2026 |
Share Statistics
NSE:IPCALAB has 253.70 million shares outstanding. The number of shares has increased by 4.96% in one year.
| Current Share Class | 253.70M |
| Shares Outstanding | 253.70M |
| Shares Change (YoY) | +4.96% |
| Shares Change (QoQ) | -3.30% |
| Owned by Insiders (%) | 7.13% |
| Owned by Institutions (%) | 53.46% |
| Float | 139.31M |
Valuation Ratios
The trailing PE ratio is 35.15 and the forward PE ratio is 29.04. NSE:IPCALAB's PEG ratio is 1.30.
| PE Ratio | 35.15 |
| Forward PE | 29.04 |
| PS Ratio | 4.61 |
| PB Ratio | 4.75 |
| P/TBV Ratio | 5.70 |
| P/FCF Ratio | 162.22 |
| P/OCF Ratio | 51.68 |
| PEG Ratio | 1.30 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.50, with an EV/FCF ratio of 166.03.
| EV / Earnings | 35.27 |
| EV / Sales | 4.72 |
| EV / EBITDA | 20.50 |
| EV / EBIT | 24.97 |
| EV / FCF | 166.03 |
Financial Position
The company has a current ratio of 2.88, with a Debt / Equity ratio of 0.07.
| Current Ratio | 2.88 |
| Quick Ratio | 1.46 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 0.31 |
| Debt / FCF | 2.53 |
| Interest Coverage | 31.98 |
Financial Efficiency
Return on equity (ROE) is 15.59% and return on invested capital (ROIC) is 15.81%.
| Return on Equity (ROE) | 15.59% |
| Return on Assets (ROA) | 9.77% |
| Return on Invested Capital (ROIC) | 15.81% |
| Return on Capital Employed (ROCE) | 18.50% |
| Weighted Average Cost of Capital (WACC) | 4.47% |
| Revenue Per Employee | 6.09M |
| Profits Per Employee | 814,852 |
| Employee Count | 17,210 |
| Asset Turnover | 0.83 |
| Inventory Turnover | 1.21 |
Taxes
In the past 12 months, NSE:IPCALAB has paid 4.82 billion in taxes.
| Income Tax | 4.82B |
| Effective Tax Rate | 24.51% |
Stock Price Statistics
The stock price has increased by +44.10% in the last 52 weeks. The beta is 0.03, so NSE:IPCALAB's price volatility has been lower than the market average.
| Beta (5Y) | 0.03 |
| 52-Week Price Change | +44.10% |
| 50-Day Moving Average | 1,943.52 |
| 200-Day Moving Average | 1,694.77 |
| Relative Strength Index (RSI) | 44.15 |
| Average Volume (20 Days) | 276,244 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:IPCALAB had revenue of INR 104.80 billion and earned 14.02 billion in profits. Earnings per share was 54.19.
| Revenue | 104.80B |
| Gross Profit | 71.80B |
| Operating Income | 19.85B |
| Pretax Income | 19.66B |
| Net Income | 14.02B |
| EBITDA | 23.91B |
| EBIT | 19.85B |
| Earnings Per Share (EPS) | 54.19 |
Balance Sheet
The company has 11.11 billion in cash and 7.53 billion in debt, with a net cash position of 3.58 billion or 14.12 per share.
| Cash & Cash Equivalents | 11.11B |
| Total Debt | 7.53B |
| Net Cash | 3.58B |
| Net Cash Per Share | 14.12 |
| Equity (Book Value) | 101.74B |
| Book Value Per Share | 353.72 |
| Working Capital | 45.20B |
Cash Flow
In the last 12 months, operating cash flow was 9.35 billion and capital expenditures -6.37 billion, giving a free cash flow of 2.98 billion.
| Operating Cash Flow | 9.35B |
| Capital Expenditures | -6.37B |
| Depreciation & Amortization | 4.06B |
| Net Borrowing | -5.77B |
| Free Cash Flow | 2.98B |
| FCF Per Share | 11.74 |
Margins
Gross margin is 68.51%, with operating and profit margins of 18.94% and 13.38%.
| Gross Margin | 68.51% |
| Operating Margin | 18.94% |
| Pretax Margin | 18.76% |
| Profit Margin | 13.38% |
| EBITDA Margin | 22.81% |
| EBIT Margin | 18.94% |
| FCF Margin | 2.84% |
Dividends & Yields
This stock pays an annual dividend of 6.00, which amounts to a dividend yield of 0.32%.
| Dividend Per Share | 6.00 |
| Dividend Yield | 0.32% |
| Dividend Growth (YoY) | 50.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 10.95% |
| FCF Payout Ratio | 51.09% |
| Buyback Yield | -4.96% |
| Shareholder Yield | -4.64% |
| Earnings Yield | 2.84% |
| FCF Yield | 0.62% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Analyst Forecast
The average price target for NSE:IPCALAB is 2,074.22, which is 8.88% higher than the current price. The consensus rating is "Buy".
| Price Target | 2,074.22 |
| Price Target Difference | 8.88% |
| Analyst Consensus | Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (3Y) | 12.58% |
| EPS Growth Forecast (3Y) | 20.73% |
Stock Splits
The last stock split was on January 10, 2022. It was a forward split with a ratio of 2.
| Last Split Date | Jan 10, 2022 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |